Xiuzhen Di
Overview
Explore the profile of Xiuzhen Di including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
121
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di X, Bai N, Zhang X, Liu B, Ni W, Wang J, et al.
Braz J Infect Dis
. 2015 May;
19(4):339-49.
PMID: 26001980
The aim of this meta-analysis was to compare the efficacy of metronidazole and vancomycin for the treatment of Clostridium difficile infection, especially to investigate which agent was superior for treating...
2.
Di X, Wang R, Liu B, Zhang X, Ni W, Wang J, et al.
J Antibiot (Tokyo)
. 2015 Mar;
68(9):551-5.
PMID: 25805069
The shortage of effective antibiotics against carbapenem-resistant Pseudomonas aeruginosa (CRPA) poses a public health threat. Combination treatment may represent a good choice for treating infections caused by CRPA. The aim...
3.
Ni W, Cai X, Wei C, Di X, Cui J, Wang R, et al.
Braz J Infect Dis
. 2015 Feb;
19(2):170-80.
PMID: 25636193
In recent years, carbapenem-resistant Enterobacteriaceae has become endemic in many countries. Because of limited treatment options, the abandoned "old antibiotics", polymyxins, have been reintroduced to the clinic. To evaluate the...
4.
Ni W, Shao X, Di X, Cui J, Wang R, Liu Y
Int J Antimicrob Agents
. 2014 Dec;
45(1):8-18.
PMID: 25465524
In order to provide preliminary guidance for rational antibiotic combination therapy in the clinic, a systematic review and meta-analysis was performed to evaluate the in vitro synergistic activity of polymyxins...
5.
Zhang X, She D, Liu Y, Wang R, Di X, Liang B, et al.
Zhonghua Nei Ke Za Zhi
. 2014 Sep;
53(7):558-62.
PMID: 25264013
Objective: To analyze the worldwide advances on bacterial quantitative proteomics over the past fifteen years with bibliometric approach. Methods: Literature retrieval was conducted throughout the databases of Pubmed, Embase and...
6.
Liu B, Liu Y, Di X, Zhang X, Wang R, Bai Y, et al.
Rev Soc Bras Med Trop
. 2014 Sep;
47(4):451-6.
PMID: 25229285
Introduction: Acinetobacter baumannii has attained an alarming level of resistance to antibacterial drugs. Clinicians are now considering the use of older agents or unorthodox combinations of licensed drugs against multidrug-resistant...
7.
Liu B, Bai Y, Liu Y, Di X, Zhang X, Wang R, et al.
J Chemother
. 2014 Jul;
27(5):271-6.
PMID: 25068186
Over the last decade, multidrug-resistant Acinetobacter baumannii (MDRAB) has emerged as one of the most problematic nosocomial pathogens. Empirical combination therapy has become a common practice to treat patients infected...
8.
Zhang X, Wang R, Di X, Liu B, Liu Y
J Thorac Dis
. 2014 Mar;
6(2):134-42.
PMID: 24605227
Background: National treatment/diagnosis guidelines for lower respiratory tract infections (LRTIs) are generally based on local epidemiological data. Etiology and drug-resistance patterns could differ between China and European/American countries, and simply...